Oncology & Cancer

Breast cancer resistance to CDK4/6 inhibitors arises in many ways

Breast cancer cells became resistant to therapeutics targeting CDK4/6, such as palbociclib (Ibrance), in multiple ways, and preclinical studies suggested different combinations of therapeutics may prevent and overcome the ...

Oncology & Cancer

To stop cancer's spread, take out its communication channels

Metastasis - or the spread of cancer from one part of the body to other parts - accounts for more than 90 percent of cancer-related deaths. Although the cells that seed metastasis and the sites that they tend to travel to ...

Oncology & Cancer

Researchers use nanotechnology to fight breast cancer

October is Breast Cancer Awareness Month, an annual campaign to increase awareness of the disease and the importance of early detection. Researchers at the University of Notre Dame are conducting innovative research aimed ...

page 7 from 25